Cargando…
Targeted Analysis of the Gut Microbiome for Diagnosis, Prognosis and Treatment Individualization in Pediatric Inflammatory Bowel Disease
We explored the fecal microbiota in pediatric patients <18 years of age with treatment-naïve IBD (80 Crohn’s disease (CD), 27 ulcerative colitis (UC)), in 50 non-IBD patients with gastrointestinal symptoms without inflammation and in 75 healthy children. Using a targeted qPCR approach, the quanti...
Autores principales: | Olbjørn, Christine, Småstuen, Milada Cvancarova, Moen, Aina Elisabeth Fossum |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319120/ https://www.ncbi.nlm.nih.gov/pubmed/35888992 http://dx.doi.org/10.3390/microorganisms10071273 |
Ejemplares similares
-
Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease – associations with disease phenotype, treatment, and outcome
por: Olbjørn, Christine, et al.
Publicado: (2019) -
Association between colic and sleep problems in infancy and subsequent development, emotional and behavioral problems: a longitudinal study
por: Valla, Lisbeth, et al.
Publicado: (2021) -
The impact of restrictions on psychological outcomes in patients with inflammatory bowel disease on biological treatment during the coronavirus pandemic in Norway
por: Opheim, Randi, et al.
Publicado: (2022) -
The role of gut microbiome in inflammatory bowel disease diagnosis and prognosis
por: Zheng, Jiaying, et al.
Publicado: (2022) -
Mortality in Patients with Inflammatory Bowel Disease: Results from 30 Years of Follow-up in a Norwegian Inception Cohort (the IBSEN study)
por: Follin-Arbelet, Benoit, et al.
Publicado: (2022)